{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:12:10Z","timestamp":1793563930812,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T00:00:00Z","timestamp":1231200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00404-008-0907-x","type":"journal-article","created":{"date-parts":[[2009,1,5]],"date-time":"2009-01-05T17:29:54Z","timestamp":1231176594000},"page":"255-261","source":"Crossref","is-referenced-by-count":24,"title":["Effects of two combined oral contraceptives containing ethinyl estradiol 30\u00a0\u03bcg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure"],"prefix":"10.1007","volume":"280","author":[{"given":"Recep","family":"Yildizhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begum","family":"Yildizhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertan","family":"Adali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Yoruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Birol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necdet","family":"Suer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,6]]},"reference":[{"issue":"6","key":"907_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09513590701325731","volume":"23","author":"S Taneepanichskul","year":"2007","unstructured":"Taneepanichskul S, Phupong V (2007) Influence of a new oral contraceptive with DRSP on lipid metabolism. Gynecol Endocrinol 23(6):347\u2013350","journal-title":"Gynecol Endocrinol"},{"key":"907_CR2","doi-asserted-by":"crossref","unstructured":"WHO (1989) The WHO multicenter trial of the vasopressor effects of combined oral contraceptives. Comparison with IUD. Contraception 40:129\u2013145","DOI":"10.1016\/0010-7824(89)90001-2"},{"key":"907_CR3","first-page":"121","volume-title":"progesterone and progestins","author":"F Wright","year":"1983","unstructured":"Wright F, Giacomini M, Riahi M, Mowszowicz I (1983) Antihormon activity of progesterone and progestins. In: Bardin CW, Milgr\u00f6m E, Mauvais-Jarvis P (eds) progesterone and progestins. Raven Press, New York, pp 121\u2013134"},{"key":"907_CR4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","volume":"61","author":"WKH Oelkers","year":"1996","unstructured":"Oelkers WKH (1996) Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61:166\u2013171","journal-title":"Steroids"},{"key":"907_CR5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/cs0490139","volume":"49","author":"S Oparil","year":"1975","unstructured":"Oparil S, Ehrlich EN, Lindheimer MD (1975) Effect of progesterone on renal sodium handling in man: relation to aldosterone excretion and plasma renin activity. Clin Sci 49:139\u2013147","journal-title":"Clin Sci"},{"key":"907_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.290.6461.13","volume":"290","author":"PB Rylance","year":"1985","unstructured":"Rylance PB, Brincat M, Lafferty K et al (1985) Natural progesterone and antihypertensive action. Br Med J 290:13\u201314","journal-title":"Br Med J"},{"key":"907_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","volume":"62","author":"R Krattenmacher","year":"2000","unstructured":"Krattenmacher R (2000) Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception 62:29\u201338","journal-title":"Contraception"},{"key":"907_CR8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0002-9378(93)90334-F","volume":"168","author":"RT Burkman","year":"1993","unstructured":"Burkman RT (1993) Lipid metabolism effects with desogestrel-containing oral contraceptives. Am J Obstet Gynecol 168:1033\u20131040","journal-title":"Am J Obstet Gynecol"},{"key":"907_CR9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","volume":"323","author":"IF Godsland","year":"1990","unstructured":"Godsland IF, Crook D, Simson R et al (1990) The effect of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 323:1375\u20131381","journal-title":"N Engl J Med"},{"key":"907_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0039-128X(69)80007-3","volume":"4","author":"SL Steelman","year":"1969","unstructured":"Steelman SL, Brooks JR, Morgan ER, Patanelli DJ (1969) Antiandrogenic activity of spironolactone. Steroids 4:449\u2013450","journal-title":"Steroids"},{"key":"907_CR11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","volume":"761","author":"P Muhn","year":"1995","unstructured":"Muhn P, Fuhrmann U, Fritzemeier KH, Krattenmacher R, Schillinger E (1995) Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann N Y Acad Sci 761:311\u2013335","journal-title":"Ann N Y Acad Sci"},{"key":"907_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","volume":"61","author":"KS Parsey","year":"2000","unstructured":"Parsey KS, Pong A (2000) An open-label, multicenters study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception 61:105\u2013111","journal-title":"Contraception"},{"key":"907_CR13","first-page":"1816","volume":"80","author":"W Oelkers","year":"1995","unstructured":"Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R (1995) Effects of a new oral contraceptive containing an antimineralocorticoid progesterone, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 80:1816\u20131821","journal-title":"J Clin Endocrinol Metab"},{"key":"907_CR14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-73-4-837","volume":"73","author":"W Oelkers","year":"1991","unstructured":"Oelkers W, Berger V, Bolik A et al (1991) Dihydrospirenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women. J Clin Endocrinol Metab 73:837\u2013842","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 11","key":"907_CR15","first-page":"981","volume":"47","author":"LP Shulman","year":"2002","unstructured":"Shulman LP (2002) Safety and efficacy of a new oral contraceptive containing drospirenone. J Reprod Med 47(Suppl 11):981\u2013984","journal-title":"J Reprod Med"},{"key":"907_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.contraception.2003.11.003","volume":"69","author":"U Gaspard","year":"2004","unstructured":"Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R (2004) A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles. Contraception 69:271\u2013278","journal-title":"Contraception"},{"issue":"Suppl 11","key":"907_CR17","first-page":"975","volume":"47","author":"IH Thorneycroft","year":"2002","unstructured":"Thorneycroft IH (2002) Evolution of progestins. Focus on the novel progestin drospirenone. J Reprod Med 47(Suppl 11):975\u2013980","journal-title":"J Reprod Med"},{"key":"907_CR18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","volume":"71","author":"C Klipping","year":"2005","unstructured":"Klipping C, Marr J (2005) Effects of two combined oral contraceptives containing estradiol 20\u00a0\u03bcg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism. Contraception 71:409\u2013416","journal-title":"Contraception"},{"key":"907_CR19","unstructured":"WHO (1989) Cardiovascular disease and steroid hormone contraception. Technical Report Series, 877. WHO, Geneva, p 89"},{"key":"907_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0010-7824(00)00159-1","volume":"62","author":"D Paulus","year":"2000","unstructured":"Paulus D, Saint-Remy A, Jeanjean M (2000) Oral contraception and cardiovascular risk factors during adolescence. Contraception 62:113\u2013116","journal-title":"Contraception"},{"key":"907_CR21","first-page":"1034","volume":"81","author":"L Speroff","year":"1993","unstructured":"Speroff L, Decherney A (1993) The advisory board for the new progestins. Evaluation of a new generation of oral contraceptives. Obstet Gynecol 81:1034\u20131047","journal-title":"Obstet Gynecol"},{"key":"907_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(01)02927-2","volume":"77","author":"MI Cedars","year":"2002","unstructured":"Cedars MI (2002) Triphasic oral contraceptives: review and comparison of various regimens. Fertil Steril 77:1\u201314","journal-title":"Fertil Steril"},{"key":"907_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0010-7824(98)00074-2","volume":"58","author":"I Wiegratz","year":"1998","unstructured":"Wiegratz I, Jung-Hoffmann C, Gross W et al (1998) Effect of two oral contraceptives containing ethinyl estradiol and GSD or norgestimate on different lipid and lipoprotein parameters. Contraception 58:83\u201391","journal-title":"Contraception"},{"key":"907_CR24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0002-9378(93)90279-R","volume":"169","author":"D Crook","year":"1993","unstructured":"Crook D, Godsland IF, Worthington M et al (1993) A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Am J Obstet Gynecol 169:1183\u20131189","journal-title":"Am J Obstet Gynecol"},{"key":"907_CR25","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference (1993) Triglycerides, high density lipoprotein and coronary heart disease. NIH consensus development panel on triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269:505\u201310","DOI":"10.1001\/jama.1993.03500040071040"},{"key":"907_CR26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0010-7824(93)90034-5","volume":"47","author":"M Nichols","year":"1993","unstructured":"Nichols M, Robinson G, Bounds W, Newman W, Guillebeaud J (1993) Effect of four oral contraceptives on blood pressure in the pill-free interval. Contraception 47:367\u2013376","journal-title":"Contraception"},{"key":"907_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","volume":"54","author":"U Fuhrmann","year":"1996","unstructured":"Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH (1996) The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 54:243\u2013251","journal-title":"Contraception"},{"key":"907_CR28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1471-0528.1993.tb14309.x","volume":"100","author":"M Akerlund","year":"1993","unstructured":"Akerlund M, Rode A, Westergaard J (1993) Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150\u00a0\u03bcg desogestrel and either 30\u00a0\u03bcg or 20\u00a0\u03bcg ethinyl estradiol. Br J Obstet Gynaecol 100:832\u2013838","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl 1","key":"907_CR29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01849449","volume":"8","author":"MJ Rosenberg","year":"1992","unstructured":"Rosenberg MJ, Long SC (1992) Oral contraceptives and cycle control: a critical review of the literature. Adv Contracept 8(Suppl 1):35\u201345","journal-title":"Adv Contracept"},{"key":"907_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0010-7824(97)00025-5","volume":"55","author":"J Endrikat","year":"1997","unstructured":"Endrikat J, M\u00fcler U, D\u00fcsterberg B (1997) A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20\u00a0\u03bcg ethinylestradiol\/75\u00a0\u03bcg gestodene and 30\u00a0\u03bcg ethinylestradiol\/75\u00a0\u03bcg gestodene, with respect to efficacy, cycle control, and tolerance. Contraception 55:131\u2013137","journal-title":"Contraception"},{"key":"907_CR31","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","volume":"89","author":"M Guido","year":"2004","unstructured":"Guido M, Romualdi D, Giuliani M, Suriano R, Selvaggi L, Apa R, Lanzone A (2004) Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab 89:2817\u20132823","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"907_CR32","first-page":"2","volume":"69","author":"WA Vloten van","year":"2002","unstructured":"van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R (2002) The effect of 2 combined oral contraceptives containing either drospirenone or cypreterone acetate on acne and seborrhea. Cutis 69(Suppl 4):2\u201315","journal-title":"Cutis"},{"key":"907_CR33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(95)00191-C","volume":"52","author":"J Endrikat","year":"1995","unstructured":"Endrikat J, Jaques MA, Mayerhofer M, Pelissier C, M\u00fcler U, D\u00fcsterberg B (1995) A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20\u00a0\u03bcg ethinylestradiol\/75\u00a0\u03bcg gestodene and 20\u00a0\u03bcg ethinylestradiol\/150\u00a0\u03bcg desogestrel, with respect to efficacy, cycle control and tolerance. Contraception 52:229\u2013235","journal-title":"Contraception"},{"key":"907_CR34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0010-7824(01)00213-X","volume":"63","author":"F Fruzzetti","year":"2001","unstructured":"Fruzzetti F, Genazzani AR, Ricci C, Negri FD, Bersi C, Carmassi F (2001) A 12-month clinical investigation with a 24-day regimen containing 15\u00a0\u03bcg ethinylestradiol plus 60\u00a0\u03bcg gestodene with respect to hemostasis and cycle control. Contraception 63:303\u2013307","journal-title":"Contraception"},{"key":"907_CR35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2004.09.005","volume":"71","author":"MF Gallo","year":"2005","unstructured":"Gallo MF, Nanda K, Grimes DA, Schulz KF (2005) Twenty micrograms vs >20\u00a0\u03bcg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials. Contraception 71:162\u2013169","journal-title":"Contraception"},{"key":"907_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.contraception.2003.10.016","volume":"70","author":"NR Melo de","year":"2004","unstructured":"de Melo NR, Aldrighi JM, Faggion D et al (2004) A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet (gestodene 75\/EE20) on body fat. Contraception 70:65\u201371","journal-title":"Contraception"},{"key":"907_CR37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2005.09.014","volume":"73","author":"RB Machado","year":"2006","unstructured":"Machado RB, Tachotti F, Cavenague G, Maia E (2006) Effects of two oral contraceptives on total body water: a randomized study. Contraception 73:344\u2013347","journal-title":"Contraception"},{"key":"907_CR38","first-page":"69","volume":"26","author":"M Franchini","year":"1995","unstructured":"Franchini M, Caruso C, Nigrelli S, Poggiali C (1995) Evaluation of body composition during low-dose estrogen oral contraceptives treatment. Acta Eur Fertil 26:69\u201373","journal-title":"Acta Eur Fertil"},{"key":"907_CR39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jcem-43-5-1036","volume":"43","author":"W Oelkers","year":"1976","unstructured":"Oelkers W, Blumel A, Schoneshofer M, Schwartz U, Hammerstein J (1976) Effects of ethinylestradiol on the renin-angiotensin-aldosterone-system and on plasma transcortin in women and men. J Clin Endocrinol Metab 43:1036\u20131040","journal-title":"J Clin Endocrinol Metab"},{"key":"907_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","volume":"323","author":"JM Kemmeren","year":"2001","unstructured":"Kemmeren JM, Algra A, Grobbee DE (2001) Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 323:131\u2013134","journal-title":"BMJ"},{"key":"907_CR41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0010-7824(01)00309-2","volume":"65","author":"IA Heinemann","year":"2002","unstructured":"Heinemann IA, Lewis MA, Assmann A, Thiel C (2002) Case control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use. Contraception 65:207\u2013214","journal-title":"Contraception"},{"key":"907_CR42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/09513590009167683","volume":"14","author":"W Oelkers","year":"2000","unstructured":"Oelkers W, Helmerhorst FM, Wuttke W, Heithecker R (2000) Effect on an oral contraceptive containing drospirenone on the renin-angiotensin-aldosteron system in healthy female volunteers. Gynecol Endocrinol 14:204\u2013213","journal-title":"Gynecol Endocrinol"},{"key":"907_CR43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0028-2243(90)90079-G","volume":"34","author":"NB Loudon","year":"1990","unstructured":"Loudon NB, Kirkman RJE, Dewsbury JA (1990) A double-blind comparison of the efficacy and acceptability of Femodene and Microgynone-30. Eur J Obstet Gynecol Reprod Biol 34:257\u2013266","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"907_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0010-7824(01)00221-9","volume":"64","author":"J Endrikat","year":"2001","unstructured":"Endrikat J, Hite R, Bannemerschul R, Gerlinger RC, Schmidt W (2001) Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20\u00a0\u03bcg ethinylestradiol\/100\u00a0\u03bcg levonorgestrel and 20\u00a0\u03bcg ethinylestradiol\/500\u00a0\u03bcg norethisterone. Contraception 64:3\u201310","journal-title":"Contraception"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-008-0907-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-008-0907-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-008-0907-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:53:46Z","timestamp":1559051626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-008-0907-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1007\/s00404-008-0907-x","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,6]]}}}